Licensed Practical Nurse in Grand Prairie, TX Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Lise Dorrough, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3249 Cathedral Dr, Grand Prairie, TX 75052 Phone: 214-793-8937    Fax: 972-262-8803

Mrs. Shelly Rose Wilkes, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3103 Parham Dr Apt 227, Grand Prairie, TX 75052 Phone: 817-495-4880    Fax: 214-235-0789

Amanda Azubike, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4593 Mt Laurel Dr, Grand Prairie, TX 75052 Phone: 972-480-1509

Oluwaremilekun Rachel Oluwasegun, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2340 Shirecreek Cir, Grand Prairie, TX 75052 Phone: 651-500-8086

Sunday Omorotiomwan, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2815 Pino, Grand Prairie, TX 75054 Phone: 817-798-0575

Irene Matuto, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1016 Gaines Mills Rd, Grand Prairie, TX 75052 Phone: 469-531-4380

Brittani Presley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4951 Eyrie Ct, Grand Prairie, TX 75052 Phone: 214-683-0051

Mrs. Teresia Mwango Maangi, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2415 Carson Trl, Grand Prairie, TX 75052 Phone: 817-602-0174

Crystal Mireles, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3111 Parham Dr Apt 151, Grand Prairie, TX 75052 Phone: 682-232-5329

News Archive

Teenager smoking on the rise

A new report from the U.S. Centers for Disease Control and Prevention (CDC) shows that only six months after Minnesota legislators eliminated the state's aggressive, successful "Target Market" youth anti-tobacco campaign, kids in Minnesota were at substantially greater risk of falling victim to tobacco addiction.

InSite Vision initiates Phase 1/2 clinical trial of ISV-303

InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.

Scientists model brain structure to help computers recognize objects

An essential question confronting neuroscientists and computer vision researchers alike is how objects can beidentified by simply "looking" at an image. Introspectively, we know that the human brain solves this problem very well. We only have to look at something to know what it is.

Prism Pharmaceuticals to be acquired by Baxter

Ligand Pharmaceuticals Incorporated announced that its partner Prism Pharmaceuticals has entered into a definitive agreement to be acquired by Baxter International Inc.. Prism Pharmaceuticals recently received FDA approval for Nexterone®, an antiarrhythmic agent which Ligand (through its CyDex Pharmaceuticals subsidiary) originally developed with its patented Captisol® formulation technology and licensed to Prism in 2006.

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.

Read more Medical News

› Verified 8 days ago